Insider Transactions in Q3 2022 at Biogen Inc. (BIIB)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Michael R Mcdonnell EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,428
-16.42%
|
$483,172
$199.79 P/Share
|
|
Sep 01
2022
|
Michael R Mcdonnell EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,746
+24.16%
|
-
|
|
Aug 01
2022
|
Nicole Murphy Head of Pharm Ops and Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-5.91%
|
$66,671
$209.26 P/Share
|
|
Aug 01
2022
|
Nicole Murphy Head of Pharm Ops and Tech |
BUY
Exercise of conversion of derivative security
|
Direct |
1,080
+16.28%
|
-
|
|
Jul 01
2022
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-3.54%
|
$15,540
$210.63 P/Share
|
|
Jul 01
2022
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
252
+10.76%
|
-
|
|
Jul 01
2022
|
Rachid Izzar Head of Global Product Strat. |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-6.55%
|
$31,080
$210.63 P/Share
|
|
Jul 01
2022
|
Rachid Izzar Head of Global Product Strat. |
BUY
Exercise of conversion of derivative security
|
Direct |
504
+18.25%
|
-
|